Results
Of the 123 GPs (13% of all screened GPs) who accepted to participate, 43 included 97 patients (1 -13 patients/GP; 0.4 patient/mo/GP; 86 being already known by the GP) during the 2-month study period. The mean age of the patients was 30 years (1 -78) , and the male/female sex ratio was 0. 87 . The mean duration of travel was 32 days (7 -365) . The mean duration between return and consultation was 10 days (0 -65). The two main purposes of travel were tourism (46%) and visiting friends and relatives in their country of origin (43%). The main areas visited were North Africa (51%), Turkey (6%), subSaharan Africa (17%), Asia Oceania (10%), the Middle East (7%), and South/Central America (7%).
The 97 patients presented with 113 health problems, 15 travelers having at least 2 problems. The main health impairments were gastrointestinal problems, respiratory tract infections, and skin diseases ( Table 1 ) . Fever of undetermined origin and related to a systemic febrile illness was observed in four patients each. Four patients were diagnosed with an imported disease (one hepatitis A, one dengue fever, and two malaria). Malaria was diagnosed in 2 (12%) of the 17 travelers who were returning from sub-Saharan Africa. Eight patients were referred for cardiac, rheumatologic, or traumatic problems and the association of different problems and viral hepatitis, and one was hospitalized for malaria.
Discussion
Despite the small amount of participating GPs and evaluated patients, this study is to the best of our knowledge the fi rst one to evaluate travel-associated diseases in returning travelers in the community through GPs. However, even a GP study may have some referral and selection biases. In addition, there is no control or comparator group of patients with new/acute health problems independently from travel seen by the GPs during the investigation period.
The most striking result of our study is that imported infectious diseases (even malaria) are uncommon (4%) when compared to studies performed in academic or tertiary care units where this fi gures varies from 8% to 26% for malaria. 1 -5 Such a difference is probably one of the consequences of the referral and selection biases in the latter studies as previously underlined. 6, 7 The travelers consulting GPs are more representative of the population than those consulting academic or tertiary care units and this is confi rmed here. Indeed, in France, where one third of the travels outside Europe concern North Africa, 8 the proportion of such travelers is less than 10% among those consulting in a specialized hospital unit in Paris. 1 In contrast, 51% of our patients were returning from North Africa, and this fi ts more with the travel habits of the French. Our study is supposed to catch the fi rst-line complaints of travelers because GPs are the fi rst-line doctors for most of the patients. Indeed, 86% of our sick travelers previously knew their GP. Health problems related to travel represented a small part of our GPs ' workload (0.4 consultation/mo/GP), although our study took place during 2 months (September and January) known for travel medicine activity in France. 8 Apart from malaria and other tropical diseases, there is a predominance of diarrhea, lower and respiratory tract infections, and skin diseases as in most of the studies performed in travel medicine units. 1 -5 Interestingly, very few of our patients (9%) were referred by GPs to specialized doctors or hospitals, and the main reasons for referral were for problems of cardiac, rheumatologic, orthopedic, or hepatic origin and multiorgan involvement. Therefore, most of our patients were not referred to units specialized in travel medicine or infectious/tropical diseases. This result if confi rmed in larger amount of patients also illustrates the referral and selection biases existing in the studies performed in specialized units.
Taken together, our results suggest that the studies performed in units specialized in infectious/tropical diseases and travel medicine probably overestimate the part occupied by imported infectious diseases and underestimate the part occupied by noninfectious diseases within the spectrum of travel-associated diseases. Nonetheless, the true denominator to assess travel-associated health risks would be a representative cohort of travelers who are prospectively assessed in terms of health problems, consultation of GPs and other medical availabilities, and hospitalization, during and after travel.
